Ambrx Biopharma Inc. (AMAM)
NYSE: AMAM
· Real-Time Price · USD
28.00
0.02 (0.07%)
At close: Mar 06, 2024, 9:00 PM
Ambrx Biopharma Revenue
Ambrx Biopharma reported an annual revenue of $7.4M, reflecting a -0.71% growth. For the quarter ending September 30, 2023, Ambrx Biopharma generated $53K in revenue.
Revenue (ttm)
$7.4M
Revenue Growth
-0.71%
Price / Sales Ratio
11.84
Revenue / Employee
$85.08K
Employees
87
Market Cap
1.77B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|